Disentangling Cutting-Edge Insights in Combination Therapy for Obesity & NASH Treatment

Time: 12:30 pm
day: Day 1 Seminar B Pre-Lunch Tracks


  • Combination of GLP-1 and other mechanism has potential to lead to better therapeutic profile
  • GIP, Amylin and GDF15 demonstrated synergy with GLP-1R agonist
  • Unravelling novel considerations for designing combination studies